$YBCN
Yong Bai Chao New Retail Corp

2024 Q4 Form 10-Q Financial Statement

#000147793224007407 Filed on November 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $7.653K
YoY Change -23.24%
Operating Profit -$7.653K
YoY Change -23.24%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$7.653K
YoY Change -23.24%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$7.653K
YoY Change -23.24%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 189.1M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00
Total Long-Term Assets $0.00
Total Assets $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $141.5K
YoY Change 43.84%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $141.5K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$3.711M
YoY Change 1.18%
Common Stock $195.5K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$141.5K
YoY Change
Total Liabilities & Shareholders Equity $0.00
YoY Change

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$7.653K
YoY Change -23.24%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Assets
Assets
0 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14155 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7322 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
0 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3371271 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3710597 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
106659 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
195496 usd
CY2024Q3 ybcn Due To Related Party Current
DueToRelatedPartyCurrent
127393 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2023Q4 us-gaap Assets
Assets
0 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
us-gaap Profit Loss
ProfitLoss
-53767 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6833 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4604 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
28056 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
49163 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There are no financial instruments that potentially subject the Company to the concentration of credit risk. The Company has not experienced losses and management believes the Company is not exposed to significant credit risks.</p>
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3710597 usd
CY2024Q3 ybcn Working Capital Deficit
WorkingCapitalDeficit
-141548 usd
us-gaap Net Income Loss
NetIncomeLoss
-34889 usd
CY2009Q3 ybcn Investor Relations Agreement Description
InvestorRelationsAgreementDescription
Pursuant to such agreement, the Company agreed to pay a fee of $1,000 per month for a period of six months beginning on August 1, 2009 and ending January 1, 2010. The Company should have issued 75,000 shares within 7 days of signing the agreement. Any payments over 45 days would be subject to a penalty fee of 10% per week
CY2010Q1 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
75000 shares
CY2009Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 usd
CY2010Q1 ybcn Additional Shares Issued
AdditionalSharesIssued
75000 shares
CY2023Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On May 11, 2023, the Company’s board of directors approved the amendment to and adoption of the amended and restated articles of incorporation (the “Amended and Restated Articles of Incorporation”), to affect a 1-for-20 reverse stock split of the Company’s outstanding common stock (the “Reverse Stock Split”). On May 17, 2023, the majority stockholders by written consent adopted and ratified the Amended and Restated Articles of Incorporation.
us-gaap Profit Loss
ProfitLoss
-34889 usd
CY2024Q3 us-gaap Sale Of Stock Percentage Of Ownership Before Transaction
SaleOfStockPercentageOfOwnershipBeforeTransaction
0.21 pure
CY2023Q3 us-gaap Sale Of Stock Percentage Of Ownership Before Transaction
SaleOfStockPercentageOfOwnershipBeforeTransaction
0.21 pure
us-gaap Sale Of Stock Percentage Of Ownership Before Transaction
SaleOfStockPercentageOfOwnershipBeforeTransaction
0.21 pure
us-gaap Sale Of Stock Percentage Of Ownership Before Transaction
SaleOfStockPercentageOfOwnershipBeforeTransaction
0.21 pure
CY2024Q3 ybcn Change In Deferred Tax Asset Valuation Allowance
ChangeInDeferredTaxAssetValuationAllowance
0.21 pure
CY2023Q3 ybcn Change In Deferred Tax Asset Valuation Allowance
ChangeInDeferredTaxAssetValuationAllowance
0.21 pure
ybcn Change In Deferred Tax Asset Valuation Allowance
ChangeInDeferredTaxAssetValuationAllowance
0.21 pure
ybcn Change In Deferred Tax Asset Valuation Allowance
ChangeInDeferredTaxAssetValuationAllowance
0.21 pure
CY2024Q3 ybcn Provision For Income Taxes
ProvisionForIncomeTaxes
0 pure
CY2023Q3 ybcn Provision For Income Taxes
ProvisionForIncomeTaxes
0 pure
ybcn Provision For Income Taxes
ProvisionForIncomeTaxes
0 pure
ybcn Provision For Income Taxes
ProvisionForIncomeTaxes
0 pure
dei Entity Central Index Key
EntityCentralIndexKey
0001284454
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
China
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189120068 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189495068 shares
CY2024Q3 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-206764
dei Entity Registrant Name
EntityRegistrantName
Yong Bai Chao New Retail Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3626387
dei Entity Address Address Line1
EntityAddressAddressLine1
No. 3205-3209, South Building, No. 3
dei Entity Address Address Line2
EntityAddressAddressLine2
Intelligence Industrial Park
dei Entity Address Address Line3
EntityAddressAddressLine3
No.39 Hulan West Road, Baoshan District
dei Entity Address City Or Town
EntityAddressCityOrTown
Shanghai
dei Entity Address Country
EntityAddressCountry
CN
dei City Area Code
CityAreaCode
86
dei Local Phone Number
LocalPhoneNumber
135-8568-1065
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
189120068 shares
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
0 usd
CY2023Q4 ybcn Due To Related Party Current
DueToRelatedPartyCurrent
99337 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
141548 usd
CY2024Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189495068 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189120068 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
195496 usd
CY2024Q3 ybcn Common Stock To Be Issued
CommonStockToBeIssued
2282 usd
CY2023Q4 ybcn Common Stock To Be Issued
CommonStockToBeIssued
2282 usd
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3371271 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3675708 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-141548 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-106659 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
7653 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
9970 usd
us-gaap Professional Fees
ProfessionalFees
34889 usd
us-gaap Professional Fees
ProfessionalFees
53767 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
7653 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
9970 usd
us-gaap Operating Expenses
OperatingExpenses
34889 usd
us-gaap Operating Expenses
OperatingExpenses
53767 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7653 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9970 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-34889 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-53767 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
0 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7653 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9970 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34889 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53767 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-7653 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9970 usd
us-gaap Net Income Loss
NetIncomeLoss
-34889 usd
us-gaap Net Income Loss
NetIncomeLoss
-53767 usd
CY2024Q3 ybcn Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
CY2023Q3 ybcn Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
ybcn Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
ybcn Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
CY2024Q3 ybcn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
189120068 shares
CY2023Q3 ybcn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
189120068 shares
ybcn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
189120068 shares
ybcn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
189120068 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-106659 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-17833 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-124492 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-9403 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-133895 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-7653 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-141548 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-44642 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-69642 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-18797 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-88439 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9970 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-98409 usd
CY2009Q3 ybcn Penalty Fees
PenaltyFees
0.10 pure
CY2023Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 usd

Files In Submission

Name View Source Status
0001477932-24-007407-index-headers.html Edgar Link pending
0001477932-24-007407-index.html Edgar Link pending
0001477932-24-007407.txt Edgar Link pending
0001477932-24-007407-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ybcn-20240930.xsd Edgar Link pending
ybcn_10q.htm Edgar Link pending
ybcn_ex311.htm Edgar Link pending
ybcn_ex312.htm Edgar Link pending
ybcn_ex321.htm Edgar Link pending
ybcn_ex322.htm Edgar Link pending
ybcn-20240930_cal.xml Edgar Link unprocessable
ybcn-20240930_def.xml Edgar Link unprocessable
ybcn-20240930_pre.xml Edgar Link unprocessable
ybcn-20240930_lab.xml Edgar Link unprocessable
ybcn_10q_htm.xml Edgar Link completed